JP2009539822A5 - - Google Patents

Download PDF

Info

Publication number
JP2009539822A5
JP2009539822A5 JP2009513791A JP2009513791A JP2009539822A5 JP 2009539822 A5 JP2009539822 A5 JP 2009539822A5 JP 2009513791 A JP2009513791 A JP 2009513791A JP 2009513791 A JP2009513791 A JP 2009513791A JP 2009539822 A5 JP2009539822 A5 JP 2009539822A5
Authority
JP
Japan
Prior art keywords
carbon atoms
pharmaceutically acceptable
formula
kit according
ome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009513791A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009539822A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2007/001528 external-priority patent/WO2007144725A2/en
Publication of JP2009539822A publication Critical patent/JP2009539822A/ja
Publication of JP2009539822A5 publication Critical patent/JP2009539822A5/ja
Pending legal-status Critical Current

Links

JP2009513791A 2006-06-09 2007-06-07 副腎のβ−１１−ヒドロキシラーゼの定量用トレーサーとしての１８Ｆ標識アルキル−１−［（１Ｒ）−１−フェニルエチル］−１Ｈ−イミダゾール−５−カルボキシレートの合成と評価 Pending JP2009539822A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81215906P 2006-06-09 2006-06-09
PCT/IB2007/001528 WO2007144725A2 (en) 2006-06-09 2007-06-07 SYNTHESIS AND EVALUATION OF 18F-LABELLED ALKYL-1-[(R)-1-PHENYLETHYL]-1H-IMIDAZOLE-5-CARBOXYLATE AS A TRACER FOR THE QUANTIFICATION OF β-11-HYDROXYLASE ENZYME IN THE ADRENAL GLANDS

Publications (2)

Publication Number Publication Date
JP2009539822A JP2009539822A (ja) 2009-11-19
JP2009539822A5 true JP2009539822A5 (enExample) 2011-06-16

Family

ID=38658301

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009513791A Pending JP2009539822A (ja) 2006-06-09 2007-06-07 副腎のβ−１１−ヒドロキシラーゼの定量用トレーサーとしての１８Ｆ標識アルキル−１−［（１Ｒ）−１−フェニルエチル］−１Ｈ−イミダゾール−５−カルボキシレートの合成と評価

Country Status (4)

Country Link
US (1) US8071785B2 (enExample)
EP (1) EP2035393A2 (enExample)
JP (1) JP2009539822A (enExample)
WO (1) WO2007144725A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2474435C2 (ru) * 2007-11-07 2013-02-10 Джи-И Хелткер БВ Стабилизация радиофармацевтических композиций
BRPI0910072A2 (pt) * 2008-03-31 2017-05-30 Massachusetts Gen Hospital composto, composição farmaceutic, e, método para prover anestesia a um mamífero.
CA2861071C (en) 2012-01-13 2017-09-12 The General Hospital Corporation Etomidate and metomidate derivatives and their use as anesthetics
GB201202420D0 (en) * 2012-02-13 2012-03-28 Ge Healthcare Ltd Radiotracer compositions
JP6048958B2 (ja) 2012-12-27 2016-12-21 日本メジフィジックス株式会社 副腎疾患の画像診断剤
JP2015110563A (ja) * 2013-11-08 2015-06-18 日本メジフィジックス株式会社 アルドステロン合成酵素阻害剤
WO2015199205A1 (ja) * 2014-06-26 2015-12-30 日本メジフィジックス株式会社 ２－（３－ピリジニル）－１ｈ－ベンゾイミダゾール誘導体化合物、及び、これを含む医薬
US11266753B2 (en) 2017-12-28 2022-03-08 Nihon Medi-Physics Co., Ltd. 2-[5-(imidazol-1-ylmethyl)pyridin-3-yl]benzimtdazole derivative compound, and medicament including same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7189859B2 (en) * 2003-08-06 2007-03-13 Ilse Zolle Radiolabelled phenylethyl imidazole carboxylic acid ester derivatives

Similar Documents

Publication Publication Date Title
JP2009539822A5 (enExample)
JP2009143956A5 (enExample)
BR0316902A (pt) Processos para preparar (+)duloxetina e hidrocloreto de (+)duloxetina, sal de ácido quiral e (+)duloxetina, di-p-toluil tartarato de (+)duloxetina, (+)duloxetina e composição farmacêutica
PT2428519E (pt) Processo para preparação de 17-o-vinil-triflatos como intermediários
SE0400235D0 (sv) New composition containing quinoline compounds
JP2012506896A5 (enExample)
CY1111275T1 (el) Κρυσταλλικη μορφη μιας ενωσης κινολινονης-καρβοξαμιδιου
JP2009501198A5 (enExample)
CY1112911T1 (el) Θεραπευτικος παραγοντας ηπατικης νοσου, που περιεχει παραγωγο 2-αμινο-1,3-προπανοδιολης ως δραστικο συστατικο
JP2005536503A5 (enExample)
WO2005110982A3 (en) Substituted 1-benzyl-4-substituted piperazine analogues
JP2007500222A5 (enExample)
RU2008127541A (ru) Новые соли
AR049681A1 (es) Macrolidos preparados a partir de actinomicetos. composiciones farmaceuticas
DE502006002659D1 (de) Verfahren zur herstellung von 5-(4-ä4-(5-cyano-3-indolyl)-butylü-1-piperazinyl)-benzofuran-2-carboxamid
RU2007119432A (ru) Способ лечения рака
JP2006523626A5 (enExample)
BRPI0510278A (pt) método para produzir compostos, produto, e, composto
JP2011502147A5 (enExample)
JP2007506664A5 (enExample)
BRPI0417300A (pt) métodos para a preparação de compostos de tiazolpirimidina
JP2007519685A5 (enExample)
JP2004525111A5 (enExample)
RU2006129945A (ru) Соль, образованная из амина и производного карбостирила
JP2010538009A5 (enExample)